| Logo | Name | Σ | Employees |
|---|---|---|---|
 |  Gubra Science of certainty Founded in 2008, we are a biotech company with two primary areas of business: Preclinical contract research organization (CRO) services and proprietary early target and drug discovery programs. Our focus is the metabolic space (e.g. obesity, diabetes, MASH and gastrointestinal diseases), where we specialize in peptide chemistry, in vivo pharmacology, ex vivo assays, molecular pharmacology, histology, imaging, stereology, NGS (next generation sequencing) and bioinformatics. Gubra is an abbreviation for GUt and BRAin, the original key focus areas of our research and expertise. We work with some of the most interesting and loyal partners and customers from across … 85 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 4 | 271 |
 | Kolibri Playing music to cells Kolibri revolutionises the way we grow and engineer cells at scale using acoustic waves. 🔍 Book a discovery call: https://calendly.com/tamsin_kolibrilab/discovery-call Showing 10x increase in cell density and 50x reduction in production costs, our patented bioreactors help our partners in drug development unlock patient access to gene therapies, with a proof of principle in AAV gene therapy. Being cell-agnostic and scalable, our process has significant potential across a range of high-value cell-based therapies - or in the cellular agriculture space more broadly. gene therapy, biomanufacturing, cellculture, acoustics, hardtech, and biotech 137 similar entities Type: Startup Activities: biotech deeptech manufacturing Technologies: Synthetic Biology | 14 | 13 |
 |  Astraveus We build high tech equipment supporting end-to-end development and manufacture of cell and gene therapies. We build high tech equipment supporting end-to-end development and manufacture of cell and gene therapies. biotech, medtech, cell therapy, gene therapy, CAR-T, MSC, iPS, ATMP, Tissue Engineering, cell based therapies, biotherapies, RMAT, and Manufacturing 428 similar entities Tags: FrenchTech2030 Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 15 | 64 |
 | Nuritas See Nature Differently Through pioneering life science and artificial intelligence, we developed our unique Nuritas MagnifierNπΦ platform that allows us to identify, unlock, clinically test and patent peptides; turning them into powerful and precise ingredients that elevate natural efficacy. We want to empower people to live healthier lives, naturally by making our everyday products healthier, safer, greener and more efficacious. From what we eat, to what we apply to our skin. By translating nature’s wisdom into innovation, together, we can change the life of billions. Pure peptides, Peptide mixtures, Hydrolysates, Multi targeted peptides, Bioinformatics, Artificial intelligence for drug discovery, Peptide … 58 similar entities Type: Startup Activities: deeptech biotech Technologies: A.I. Synthetic Biology | 23 | 58 |
 | Turbine We are building the world’s leading predictive simulation of patient biology. Truly meaningful medicine comes from breakthroughs?in deeply understanding patient biology. We are building the world’s first open simulation platform of patient biology. Drug Discovery, Biotechnology, Artificial Intelligence, in silico, Cell Biology, Simulated Experiments, Bioinformatics, and Pharmaceuticals 180 similar entities Type: Startup Activities: deeptech biotech Technologies: A.I. Synthetic Biology | 8 | 103 |
 | Ingenza Ltd ADVANCED BY NATURE. Ingenza Ltd. is a boutique, employee-owned CRDMO that develops smarter bioprocesses across life sciences and industrial biotech. With over two decades of experience, Ingenza combines molecular biology, biocatalysis, and computational design into a platform-based approach that enables predictable, scalable, and efficient biomanufacturing. At the heart of our offering are proprietary inGenius platform that drive decision-making and accelerate development: codABLETM – our machine learning-driven gene optimization tool for intelligent codon selection and expression tuning Rapid Strain and Cell Line Development – modular workflows for host selection, expression screening, and stability assessment Integrated Process Development – upstream and downstream … 125 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 3 | 51 |
 | Abolis Biotechnologies Decipher - Innovate - Build Abolis is a French company delivering high-impact innovations in biotechnologies. We provide tailor-made industrial solutions based on micro-organisms. Founded in 2014, Abolis is made up of a team of 66+ people. Determined to become a key player in the transformation of manufacturing, we reinvent the future of numerous industries - from food to healthcare, cosmetics and chemicals. We rely on biotechnologies and the untapped potential of micro-organisms to develop new solutions economically viable. We take up the industry's current challenges by: · Using renewable raw materials · Relocate essential production and secure supply chains · … 66 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 21 | 53 |
 | MD Start MD Start is a fund, a team of entrepreneurs and an incubator combined, aimed at transforming innovative ideas into medical realities. Our mission is to incubate medical device innovations to the point where proof-of-principle in patients is demonstrated, allowing for interest from traditional investors and our continued funding. Our team operates the projects and new companies to bridge the gap between science and clinical experience. We source innovations that are too early for large corporate or venture investors. These inventions arise from clinicians all over the world who do not wish to become entrepreneurs Our ambition is to turn these … 95 similar entities Type: Incubators & VCs SMB Activities: deeptech healthtech Technologies: Synthetic Biology | 0 | 4 |
 | Discovery Park A thriving life science community for entrepreneurs and leaders and the ideal environment for businesses to succeed 🧪 Discovery Park is the ideal environment for life science businesses to succeed. From state-of-the-art labs and offices to comprehensive support, we work in partnership with you to provide firm foundations for every stage of your growth. Within easy reach of London, our location provides access to a wealth of resources and opportunities with the freedom to expand, making it the optimal setting for brilliant minds to unlock the potential of scientific breakthroughs. Science, Technology, Manufacturing, Research , Research and Development, Enterprise, Logistics, … 75 similar entities Type: Startup Activities: deeptech manufacturing Technologies: Synthetic Biology | 24 | 79 |
 | MicroBrain Biotech Make your Own Neuronal Network At MicroBrain Biotech, our mission is to revolutionize drug development by embracing ethical and cruelty-free practices, putting humanity at the center of our work, and relentlessly pursuing groundbreaking discoveries. We are committed to creating innovative solutions that improve the quality of life for patients and their families, while treating all living beings with compassion and respect. Through collaboration, scientific excellence, and a commitment to sustainability, we aim to leave a lasting positive impact on the world of healthcare and beyond. Type: Startup Activities: deeptech biotech healthtech Technologies: Synthetic Biology | 0 | 4 |
 | FARMALIDER Driving Innovation in Health At Farmalider, we believe in ideas as a driving force for progress. We know that true innovation comes from merging a brilliant idea with the ability to transform it into real improvements in people's health. As a pioneering strategic partner in pharmaceutical innovation, we offer a comprehensive service that spans from ideation and development to intellectual property, licensing, manufacturing, and supply. Our commitment to continuous improvement, solid knowledge, and adaptability allows us to make a difference every day, building sustainable relationships with our clients. For this reason, we offer both prescription and over-the-counter pharmaceutical products, patents, … 22 similar entities Type: SMB Activities: deeptech Technologies: Synthetic Biology | 3 | 108 |
 | Bioptimus We build foundation models that will transform biology. We use cutting-edge technology to transform multiscale data into actionable representations to fuel breakthrough discoveries. Join us on our mission to build foundation models that transform biology. artificial intelligence, biology, and foundation models 58 similar entities Type: Startup Activities: biotech it services Technologies: Generative A.I. A.I. | 15 | 28 |
 | X'PROCHEM We produce customised chemical proteins to help our bio-pharms partners to accelerate their projects. 🧪 X’PROCHEM is a biotech company who invented an advanced and proprietary ligation technology. We help our bio-pharma partners design and create therapeutic, vaccine and diagnostic proteins. Unlike recombinant fermentation we can produce proteins containing up to 400 amino acids, without isoforms, endotoxins, or biological contaminants. We co develop solutions with our partners to understand the real needs within the context. By working closely, we can adapt to changing needs and circumstances. protein, purification, synthesis, protein production, peptide synthesis, and life sciences 64 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 1 | 14 |
 | Biotrains CONNECT COLLABORATE EVOLVE Biotrains is world's leading provider of business conferences, training, managed events and Consulting services for Pharmaceutical, Biotech, Healthcare and Medical Device industry. We at Biotrains recognize that knowledge is power and continuous learning is fundamental for the success of all business and academia. We deliver world-class content and expert knowledge that our clients demand to outshine in their professional roles giving a competitive advantage to their organization. We organize specialized technical events in areas including • Lyophilization/Freeze Drying • Bioprocess Development & Manufacturing • Drug Development, Drug Discovery • Diagnostics & Personalized Medicine • Healthcare, Home Healthcare … 81 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 4 | 33 |
 | UK Biocentre A market-leading provider of high throughput end-to-end sample processing and storage solutions. At UK Biocentre we strive to use our expertise and collaborative approach to deliver innovative technology and solutions. Established by UK Biobank in 2011, we are a leader in sample management, high-capacity bioprocessing, and storage. We’re a not-for-profit organisation that supports and facilitates large-scale research studies. We enable life-changing research in the academic, pharmaceutical and biotech research communities offering solutions from sample processing and analysis to genomics and long-term sample cold storage. We are committed to consistently driving quality and innovation. Our heritage, deeply rooted in our dedication … 60 similar entities Type: Startup Activities: deeptech Technologies: Data Analytics | 2 | 202 |
 | Bioxegy Pioneering biomimicry in Europe. Together with your R&D-I teams, we engineer breakthrough bio-inspired technologies. A new ally for your innovation : 3.8 billion years of R&D. At Bioxegy, we stand for a world where mankind thrives and progresses in harmony with its environment. In today’s context of constant challenges and strong competitive pressure, this is a major challenge for companies. We believe that their success will first and foremost rely on their capacity to imagine and explore new ways to innovate. Combining competitivity and sustainable development is now paramount. To answer this challenge, Bioxegy relies on more than 3.8 billion … 65 similar entities Type: Startup Activities: cleantech greentech manufacturing biotech deeptech Technologies: Decarbonization | 30 | 26 |
 |  AbLeads AbLeads is a young biotech startup developing innovative solutions in Oncology, through the generation of novel, personalized therapeutic antibodies. Learn More on https://ableads.fr Biotechnology, Oncology, Immunotherapy, Therapeutic Antibodies, and Personalized Medicine 574 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 0 | 1 |
 | Zymvol Biomodeling Accelerating enzyme discovery and design through computer simulations We are a biotech company that delivers tailor-made enzymes designed to outperform client's needs. At Zymvol we combine cutting edge technology with top scientific expertise to make biocatalysis available to everyone. We are a trusted partner that supports our customers in every stage of their bio-journey: from project definition and prioritization to the development and delivery of tailored enzymes. Our unique approach enables unparalleled accuracy and predictability, along with unprecedented speed. We are the perfect partner for companies aiming to maximize their return on investment and meet their timelines in biocatalysis development. … 65 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 9 | 32 |
 | SYNTHELIS Cell-free systems expert ! The futures of protein ! Best chance for your protein projects ! A French biotech company located in Grenoble, at the heart of the French Alps, Synthelis is the leading French expert in Cell-Free systems. Our proprietary cell-free expression technology has established itself as a benchmark across Europe and is now on a path to compete with US leaders in the field. The need to produce every possible type of protein quickly, reliably and economically is a real challenge in research fields today, and it will become increasingly important to industry in the decades to come. … 61 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 18 | 9 |
 | 10x Genomics Powering researchers’ insights with innovative single cell, spatial biology, & in situ tools. 🧬🔬 Cells are the basic unit of life. They power everything we do, and unlocking their secrets is the key to advancing our knowledge of every facet of biology, from development to disease. Our single cell, spatial, and in situ tools enable researchers to answer pressing questions about cells and their functional contributions to oncology, immunology, neuroscience, and much more—as evidenced by more than 5,500 publications citing our technology. We are dedicated to building the best products, delivering the best customer experience, and creating the best team … 21 similar entities Type: SMB Activities: industry 4.0 it services Technologies: Synthetic Biology | 5 | 2,265 |
 | Tebubio Facilitators of Life Sciences Research We facilitate Life Sciences Research every day, contributing to advance Science for a brighter future. Through our local offices located across Europe, we support Life Sciences and Biotechnology Researchers with a unique, holistic range of solutions to advance their projects faster: - We enable researchers to be at the forefront in their Research with access to cutting-edge biological solutions sourced from reputed global Life Sciences suppliers, carefully selected by our Scientific Team for their relevance and evaluated for their ethical and legal compliance. - We accelerate their Research thanks to our Contract Research Services’ … 102 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 15 | 81 |
 | HTS BIO Laboratories Professional hygiene proper. Our core business: biotechnologies applied to the environment. Since 1988, in collaboration with world -renowned research centers such as #CNRS, Bio HTS imagines, designs and manufactures ecological, ultraperformant products and solutions in France and at the forefront of innovation for #hygiene, #Nettotage, Bioremediation (biological depollution), agriculture, aquaculture, water treatment. They are developed thanks to exclusive microbiological processes and meet the largest economic and environmental requirements. Increased biotechnology Do you have innovative projects? Do you want to propel innovative technology in distribution, responsible consumption? Increased biotechnology is the alliance of your ideas with our #biotech solutions. Biotechnologies, biotraitments, … 78 similar entities Type: SMB Activities: deeptech water management | 1 | 41 |
 | TAGC Understanding biological complexity, from genotype to phenotype, with interdisciplinary approaches. Our laboratory is a joint research unit of INSERM and the University of Aix-Marseille. We seek to decipher the complex biological mechanisms involved in the development or physiological functioning of an organism. Our research project is organized around two axes, one entitled "bioinformatics and genomics of molecular networks", the second "genetics and genomics of multifactorial diseases". We conduct not only basic research projects, but also collaborative projects with hospitals and biotech companies. This policy is fully in line with INSERM's strategic plan. Our ambition is both to contribute to a … 27 similar entities Type: SMB Activities: deeptech Technologies: Synthetic Biology | 1 | 16 |
 | ResoTher Pharma Building on innovative science to create treatments for patients in need ResoTher Pharma ApS is a biotechnology company focused on developing novel and effective peptide therapeutics for cardiovascular disease by targeting inflammation. Biotechnology, Drug Development, and Pharmaceutical Industry 662 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 0 | 17 |
 | Novalix Novalix is a premier drug discovery CRO Novalix is a premier drug discovery partner to biotech firms and pharmaceutical companies. We apply our exceptional scientific talent and exclusive resources across our platforms to improve the odds of success at each critical pre-clinical stage. The better the science, the better the outcomes. For additional information visit www.novalix.com Target based drug discovery, NMR, SPR, Epigenetic targets, Nuclear receptors, Protein-ligand co-crystal structures by XRD, Native mass spectrometry, FBDD, Organic Chemistry, cryo-electron microscopy, Chemical development, Medicinal chemistry, Structural Biology, in vitro pharmacology, DNA-encoded libraries, Flow chemistry, and Chemical process research 128 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 36 | 373 |
 | Greentech We source nature to resource the future. Pioneering ethical biotechnologies, from plants, marine and microbial origin. Our Credo We are biotech pioneers, we are scientists, we are explorers. Working across all continents, in all climates, in all of the worlds’ oceans. We create high-tech active ingredients from natural sources from plant, marine and microbial worlds. We source the best that nature has to offer, to the benefit of everyone: in cosmetics, healthcare, human and animal nutrition, agronomy and environment. We operate worldwide to build sustainable subsidiaries that are founded on the principles of protecting biodiversity and human relationships. No nature, … 51 similar entities Type: SMB Activities: deeptech Technologies: Bio sourced materials | 15 | 415 |
 | PacBio Our mission is to enable the promise of genomics to better human health. At PacBio, we’re devoted to empowering you. Pioneering the future through biology takes vision. You have to look beyond the status quo to what’s possible. We know your vision can reveal the full potential of the genome, advance human health and the health of our planet. And that is why your vision and pursuit are at the very center of what our company does — our product design, our customer support model, our partnerships, and even our identity. We create the world’s most advanced sequencing systems to … 13 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 5 | 657 |
 | CellVoyant We see the future in cells CellVoyant is an AI-first biotechnology company with a mission to create novel stem cell-based therapies for chronic diseases. Our technology uses AI-first live cell imaging to predict and optimise stem cell differentiation, to controllably manufacture any cell and tissue in the body at scale. CellVoyant is built on foundational work from the Carazo Salas lab at the University of Bristol. We’re working at the exciting intersection of cell biology, computer vision, engineering, and machine learning to industrialise next-generation science from research into the real world. Our mission is bold and ambitious and we have … 71 similar entities Type: Startup Activities: deeptech biotech Technologies: A.I. Synthetic Biology | 4 | 17 |
 | AFFIRMA BIOTECH SL Affirma Biotech develops new products to overcome the challenge of Multi Drug Resistant and Chronic Infections Affirma Biotech is a start-up company specialized in the discovery and development of new anti-infective drugs via immunomodulation. 438 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 0 | 5 |
 | Molecular Devices Advancing Discovery Molecular Devices is one of the world’s leading providers of high-performance life science technology. We make advanced scientific discovery possible for academia, pharma, and biotech customers with platforms for high-throughput screening, genomic and cellular analysis, colony selection and microplate detection. From cancer to COVID-19, we've contributed to scientific breakthroughs described in over 230,000 peer-reviewed publications. Over 160,000 of our innovative solutions are incorporated into laboratories worldwide, enabling scientists to improve productivity and effectiveness – ultimately accelerating research and the development of new therapeutics. Molecular Devices is headquartered in Silicon Valley, Calif., with best-in-class teams around the globe. Over … 54 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 3 | 738 |
 | Batavia Biosciences Accelerate Biotechnology Batavia Biosciences is a science-based CDMO that offers personalized services that fully support all the stages of biopharmaceutical development, from cloning to GMP manufacture and release of clinical material for phase I/II studies. We are not your standard CDMO - our customers regularly refer to us as their product development partner and thought partner. We focus on the early stages of product development with services ranging from DNA cloning, mammalian cell line generation, upstream process development, purification development, product characterization to clinical manufacturing. Headquartered in Leiden, The Netherlands, Batavia Biosciences is privileged to have strong strategic partners in … 91 similar entities Type: Startup Activities: deeptech Technologies: Synthetic Biology | 3 | 160 |
 | 9th Dimension Biotech, Inc. Planting the seeds of human health. PLANTING THE SEEDS OF HUMAN HEALTH. First in the world to offer the age-reversing, lifespan and healthspan enhancing Osmotin plant protein product line. Available now in the US and worldwide. Visit www.osmotin.com for more info. biotech, cell life and death cycle, plant biotechnology, human health, age-reversing, and agriculture 61 similar entities Type: Startup Activities: biotech deeptech agritech Technologies: Synthetic Biology | 0 | 2 |
 | MacroGenics, Inc. MacroGenics is a leader in the discovery and development of innovative medicines that utilize our next generation antibody-based technologies. Our team of 300+ dedicated individuals is advancing a pipeline of product candidates to treat patients with cancer. Our products and platforms have attracted multiple partnerships with leading pharmaceutical and biotechnology companies around the globe. The Company considers its employees to be its most valuable asset and we are committed to providing opportunities for individuals to learn and grow as a means to further their professional development. MacroGenics' corporate culture promotes an atmosphere of innovation, open communication and teamwork where employees … Type: SMB Activities: deeptech biotech Technologies: Synthetic Biology | 1 | 386 |
 | Camena Bioscience Unlocking access to genes with unparalleled accuracy Our mission is to enable synthetic biologists, by using our technology to unlock access to genes with unparalleled accuracy. We produce genes for a range of biotechnology customers including those in the pharmaceutical, agriculture and diagnostics sectors. Our technology offers access to long and complex gene sequences, which are normally difficult to produce. We are based in Cambridge UK, but we serve companies across the world. Camena's technology is positioned to enable researchers and the synthetic biology revolution. Twitter: @camenabio DNA synthesis, Complex genes, Synthetic Biology, synbio, and Gene synthesis 110 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 1 | 31 |
 | Twist Bioscience Synthetic DNA for Health & Sustainability Twist Bioscience is a synthetic biology company based in South San Francisco, California. The company has developed a proprietary silicon-based manufacturing process for the production of synthetic DNA. Twist Bioscience serves Life Science researchers who are changing the world for the better. Coming from diverse fields of medicine, agriculture, industrial chemicals and data storage, scientists use our synthetic genes, oligo pools, and NGS target enrichment to better lives and improve the sustainability of the planet. Twist Bioscience is uniquely positioned to help accelerate these efforts by providing precision at a scale that is otherwise … 49 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 28 | 1,095 |
 | Bioo Creating the next biotech cities in the world through unique technologies powered by nature. From living biological batteries below earth that generate energy, save water and compensate heat; to bioluminescent plants, able to reduce energy use and light pollution; and even biological activators, using leaves to create automations between the human beings and plants, are some of the unique biotechnologies developed in our labs. Bioo is ideating, installing and developing buildings and parks around the planet by becoming its biotech partner, not only incorporating the first system in the world that recovers the economical investment of its green areas, but … 88 similar entities Type: Startup Activities: cleantech biotech deeptech energytech greentech Technologies: Decarbonization | 10 | 25 |
 | Latent Labs Frontier models for all molecules of life. We are making biology programmable to transform health and sustainability for the benefit of all. We are a frontier AI lab building foundational models that capture the fundamentals of biology. We empower partners with breakthrough generative AI to gain unprecedented control over molecular biology, creating new antibodies, optimizing existing enzymes, and advancing genetic engineering. Contact us to work with us today. 53 similar entities Type: Startup Activities: biotech healthtech deeptech Technologies: A.I. Generative A.I. | 2 | 15 |
 | Bioscibex At Bioscibex, we are redefining bioprocessing with innovative single-use bioreactor solutions tailored for modern biologics and cell therapy manufacturing. Our mission is to empower researchers and manufacturers with tools that simplify processes, enhance scalability, and improve efficiency. 260 similar entities Type: Startup Activities: deeptech Technologies: Synthetic Biology | 3 | 5 |
 | ExoLab Italia Within nature. We create a new innovative raw material based on plant exosomes from Italian organic agriculture to revolutionize the nutraceutical and dermocosmetics products. We are scientists with 20 years of research in the exosomial world behind them. We are the innovation that starts from a basic scientific research carried out with curiosity and desire to always create new products to change the world. We are the sustainability that starts from the biological plant world. Biotech and innovation 56 similar entities Type: Startup Activities: deeptech Technologies: Bio sourced materials | 0 | 13 |
 | BioNTech SE Our vision is to harness the power of the immune system to develop novel therapies against cancer & infectious diseases. Biopharmaceutical New Technologies (BioNTech) is a global biotechnology company aspiring to translate science into survival by developing new immunotherapies utilizing the full potential of the immune system to fight cancer and infectious diseases. BioNTech is headquartered in Mainz, Germany, and operates globally with almost 7.000 pioneers. Our work is powered by one mission: Improving the health of people worldwide. We believe that scientific rigor and passion are the driving forces that are essential for innovative progress. BioNTech was founded in … 45 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 41 | 4,991 |
 | bit.bio The Cell Coding Company bit.bio is an award-winning human synthetic biology company - our mission: coding cells for novel cures. We have developed an end-to-end platform for the creation of any human cell type. With our cutting-edge and patent-protected opti-ox precision cell programming technology, we can deterministically program human iPSCs into a chosen cell identity with unprecedented biological consistency at an industrial scale, and approximately 10 times faster than conventional methods. Our platform has the potential to unlock a new generation of medicines. Our io Cells research products provide scientists access to highly characterised, consistent, scalable human cells that enable … 65 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 0 | 185 |
 | eXmoor Pharma Integrated CDMO & Consultancy | Cell & Gene Therapy Experts | From Strategy to GMP Manufacturing & Facility Design eXmoor Pharma is more than a CDMO—we are your expert partner in cell and gene therapy development. As the only integrated CGT CDMO with embedded consultancy expertise, we support clients at every stage of their journey, from early-phase strategy to GMP manufacturing and commercialisation. For over 20 years, we have provided specialised CMC consulting, process development, and GMP clinical manufacturing to more than 170 clients. Our industry-leading scientists and strategists help biotech and pharma companies accelerate innovation while reducing risk and … 52 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 3 | 77 |
 | MaxCyte, Inc. Let's Build Better Cells Together We invest in our partners early on, working side by side in optimizing their processes to derisk their path to the clinic faster. Our ExPERTTM platform, which is based on our Flow Electroporation® technology, has been designed to support the rapidly expanding cell therapy market and can be utilized across the continuum of the high-growth cell therapy sector, from discovery and development through commercialization of next-generation, cell-based medicines. The ExPERT family of products includes: four instruments, the ATxTM, STxTM, GTxTM and VLx TM; a portfolio of proprietary related processing assemblies or disposables; and software protocols, … 313 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 4 | 131 |
 | MSD España We invent for life! In MSD -known as Merck & AMP; Co., Inc. in the United States and Canada, based in Rahway, New Jersey- We are united by our purpose of using science potential to save and improve lives in the world. For more than 130 years, we have contributed hope through the development of important medicines and vaccines. We aspire to be the leading biopharmaceutical research company of the world and, at present, we are at the forefront of research in innovative health solutions to advance the prevention and treatment of human and animal diseases. We encourage a diverse … 70 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 8 | 436 |
 | Sensible Biotechnologies Unlocking the next generation of mRNA medicines. At Sensible Biotechnologies, we are building best-in-class platform for manufacturing of high-quality mRNA in a scalable way to unlock the next generation of mRNA medicines and strengthen the global biosecurity. 109 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 1 | 21 |
 | Koniku Bio is TechTM At Koniku Inc., we take the view that a biological neuron is a *material*. An intelligent material or component to be utilized in real life products or devices. Clearly, this proposition opens up a unique set of technology challenges, solvable. It simultaneously offers up an unimaginably vast trove of opportunities. Opportunities ranging from pure-play neurotech, *living devices* to advanced brain-machine interfaces. Koniku is the worlds first corporation of its kind. We are the leading brand in neurotechnology devices. Our goal is to harness the "raw" biological basis of intelligence. Our maxim is: “Bio is TechTM”. We are … 12 similar entities Type: Startup Activities: biotech deeptech Technologies: Affective Computing New Materials Synthetic Biology | 11 | 7 |
 | Future Fields We use fruit flies to help scientists change the world. Future Fields is a fly biotechnology company based in Edmonton, Canada. Founded in 2018, Future Fields is on a mission to change how we do science for humanity and the planet. Our biomanufacturing platform, the EntoEngineTM, is the first synthetic biology system in the world to use fruit flies for recombinant protein production. Powered by people and fly by design, we’re equipping industries with the biomolecular tools they need to sustainably, ethically, and economically conduct great science. Future Fields is a proud business member of 1% for the Planet, a … 7 similar entities Type: Startup Activities: agritech Technologies: Synthetic Biology | 6 | 42 |
 | Reshape Biotech Accelerating the pace of R&D. Reshape Biotech is building the next generation of lab automation robots. Our customers are biotech companies tackling the world’s biggest problems - be it alternative protein development or sustainable agriculture. Reshape Biotech is the scaling factor for these companies, as we let researchers collaborate globally on experiments and increase their throughput >500x. The team is highly multi-disciplinary, employing everything from PhD’s in biology to hardware and software engineers. We work closely together, and you will be exposed to a truly vertical team. We’re a fast growing startup with an incredibly ambitious team, dead-set on reinventing … 63 similar entities Type: Startup Activities: deeptech biotech Technologies: Robotics | 3 | 73 |
 | Evonetix Ltd Technology to ignite the biology revolution We are a Cambridge-based company developing a radically different approach to gene synthesis. Our desktop DNA synthesis platform will provide the ability to synthesise DNA at unprecedented accuracy, scale and speed, accelerating scientists' ability to use synthetic biology on a scale not currently possible. Biotechnology, Synthetic Biology, DNA synthesis, Gene synthesis, and synbio 165 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 3 | 21 |
 | enginzyme Developing technologies to meet the sustainability goals of the future Our ambition is to play a key role in tackling climate change, by enabling green chemistry for every industry. We do this by creating the most general and efficient technology platform for chemical production that the world has ever seen. That’s a big claim, but we can stand behind it. By bio-upgrading the chemical industry with our cell-free biomanufacturing platform, we can produce the products that modern society relies on in a truly sustainable way. The technology platform utilises nature’s catalysts, enzymes, by combining the power of biology with the … 63 similar entities Type: Startup Activities: biotech cleantech deeptech energytech greentech Technologies: Decarbonization | 8 | 43 |
 | EnteroBiotix Mastering the microbiome, transforming lives® EnteroBiotix is a leading microbiome therapeutics platform company that is focussed on transforming the standard of care for patients battling debilitating diseases and infections linked to disruptions to structure and function of the gut microbiome. 201 similar entities Type: Startup Activities: deeptech biotech healthtech Technologies: Synthetic Biology | 2 | 59 |
 | BioCorteX We believe that everyone - irrespective of who they are or where they live - deserve medications that work We believe that everyone - irrespective of who they are or where they live - deserve medications that work 215 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 3 | 15 |
 | OpenCell HIRING! Biotech makes the world a better place to live, so we’re making labs that are a better place to work. With so much potential for biotech to make the world a better place to live, we knew we needed to make the lab a better place to work. We’re a team of scientists and designers who have meticulously studied the in-lab experience, getting a detailed understanding of workflows and identifying common pain points that routinely cost scientists time and money. Our BioHotel labs are designed with biotech startups in mind: - Short term, flexible leases - Central London locations … 58 similar entities Type: Startup Activities: biotech deeptech | 5 | 8 |
 | Biotech Primer Expert-Led Life Sciences Training and Certifications for Non-Scientists to Advance Your Career Biotech Primer’s mission is to provide high-quality educational resources to professionals in the life sciences sector, focusing on the unique needs of non-scientists. With over 150,000 professionals trained since its founding in 2001, we offer a wide range of specialized courses that cover essential topics such as drug development, biotech business strategies, medical device development, and biotech manufacturing processes. Our programs are designed to make complex scientific concepts accessible, empowering professionals to understand the intricacies of the life sciences industry and excel in their roles. Biotech Primer’s courses … 57 similar entities Type: NGO, Think-tanks, Ed, & Culture SMB Activities: edtech Technologies: Synthetic Biology | 1 | 10 |
 | ConductScience We Conduct Science the right way. Let’s bring back the Joy of Discovery At ConductScience, we partner with small, boutique manufacturers of specialized scientific equipment to offer researchers unique, high-quality tools that meet the precise needs of their studies. We understand that groundbreaking discoveries require innovative solutions, which is why we work closely with niche suppliers to ensure scientists have access to cutting-edge technology that might not be available from larger, mass-market suppliers. neuroscience and biotech 69 similar entities Type: SMB Activities: biotech deeptech healthtech Technologies: Data Analytics | 1 | 8 |
 | AUM Biosciences Advancing precision oncology therapeutics designed to deploy multi-faceted inhibition to reverse cancer resistance AUM Biosciences is focused on advancing a clinical pipeline of precision oncology therapeutics designed to deploy multi-faceted inhibition strategies to reverse cancer resistance biotech, oncology, drug development, Asian-biotech, Precision medicine, Digitalhealth, cancer, and small molecules 550 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 3 | 17 |
 | Unicorn Biotechnologies Liberating scientists & scaling cell biology Today, biologists spend too much time performing tedious manual tasks. Biologists should spend time on what they're exceptional at: pushing the frontiers of science and creating new medicines and products. We build intelligent machines that decouple biology from manual labor. This accelerates research and provides clear paths to scaling innovations from the lab bench to the factory floor. 72 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 4 | 11 |
 | ProQR Therapeutics Advancing our proprietary AxiomerTM RNA-editing platform technology Changing lives is what drives us at ProQR Therapeutics. We are advancing our proprietary AxiomerTM RNA-editing platform technology. Our highly energetic team strives to combine innovative technologies and entrepreneurism to make a meaningful impact on the lives of individuals and the people around them. If you are up to this challenge and like to be part of our team, check out our website for vacancies: http://www.proqr.com/careers/ RNA therapeutics, Drug development, Rare Diseases, Genetic Diseases, Orphan drugs, Pharmaceuticals, and RNA editing 86 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 4 | 181 |
 | Genewity B.V. Genewity is a pioneering biotech start-up focused on advanced thymus-driven therapies for immune reconstitution. Supported by the extensive business expertise of our management and advisors, we are at the forefront of developing and commercialising breakthrough therapies. With over 150 years of combined experience in immunology and gene therapy, our team is uniquely positioned to drive advancements in the field. 275 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 0 | 14 |
 | Cell Press Cell Press publishes over 50 scientific journals across the life, physical, earth, and health sciences, both independently and in partnership with scientific societies. Our story began over 45 years ago with the journal Cell and a commitment to publishing exciting biology. Today, we are bringing our editorial excellence, commitment to innovation, unparalleled reach and visibility, and passion for advocacy to all areas of scientific exploration as we work to publish and share science that inspires. To learn more, visit www.cell.com/about. Publishing, Biomedical Journals, Life Science Journals, and Research Reviews 11 similar entities Type: SMB Activities: deeptech biotech Technologies: Synthetic Biology | 26 | 396 |
 | MycoWorks We’re on a journey to Grow the Future of Materials. We’re on a journey to Grow the Future of Materials. How? By unlocking the unique properties of mycelium, the root structure of mushrooms. Our patented technology, Fine MyceliumTM, unleashes a new class of materials crafted from nature, engineered for performance, and built for a resilient future. Our impact on future generations steers our innovations today. From our expertise in mycology and materials science to our manufacturing innovations, we’re creating new possibilities for industry. We’re an outstanding team of scientists, engineers, product experts, artists, leaders—and you. Biomaterials, Biotechnology, Design, Composites, Sustainability, … 23 similar entities Type: Startup Activities: biotech fashtech Technologies: New Materials Synthetic Biology | 10 | 240 |
 | Agios Pharmaceuticals Where science meets heart. Passionately committed to transforming the lives of people with genetically defined diseases. Agios is a biopharmaceutical company that is fueled by connections. We are passionately committed to applying our leadership in the field of cellular metabolism to create life-changing therapies for people living with rare diseases. The bonds we build with patient communities, healthcare professionals, partners and colleagues help elevate our thinking and propel our science to new heights. These connections, combined with our cellular metabolism expertise, have fueled the development and approval of our first-in-class pyruvate kinase (PK) activator, as well as other investigational therapies. … 60 similar entities Type: Startup Activities: biotech deeptech healthtech Technologies: Synthetic Biology | 9 | 609 |
 | Ginkgo Bioworks, Inc. Making biology easier to engineer. At Ginkgo, we use biology to grow the future. Companies across industries leverage our platform to design, develop, and optimize products for a breadth of commercial applications. We help our partners grow key ingredients for vaccines, crops that rely less on fossil fuel-based fertilizers, plant-based meat that tastes like the real thing, materials for the next generation of circular fashion, and so much more. We know our unique experiences, ideas, and perspectives are essential to our success and enable us to make biology easier to engineer and ensure equitable distribution of the benefits of our … 73 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology SaaS | 15 | 930 |
 | Conagen Synthetic Biology & Biological Manufacturing. #bioamazing Conagen is an accomplished biotechnology company located in the greater Boston biotech corridor. We innovate and develop synthetic biology solutions for supporting global partners across a spectrum of current and developing markets. From our proprietary strain development to fermentation and process scale-up, Conagen impacts partners’ abilities to sell and market products in the food, nutrition, flavor and fragrance, pharmaceutical, and renewable materials industries. Our bio-manufacturing capabilities, coupled with extensive platforms of enzymes and microorganisms, gives us the edge in commercial biotechnology. Nature is our inspiration for designing metabolic pathways, improving production organisms, and optimizing … 62 similar entities Type: Startup Activities: manufacturing deeptech Technologies: Bio sourced materials | 0 | 25 |
 | Intarcia Therapeutics, Inc. We operate with a “No Analog” mindset—continually pushing boundaries, navigating new terrain and unleashing fresh thinking. We are committed to seeking better outcomes which compels us to ask questions that have not been asked before or remain unresolved. We are driven by a desire to create meaningful impact across business, health and society to ease the burden on people living with chronic diseases. Intarcia is a rapidly emerging biotech company dedicated to redesigning the treatment, prevention and experience of chronic disease. Our cross-disciplinary teams include forward-thinking scientists and entrepreneurs collaborating in a fast-paced environment redefining the future of medicine. 19 similar entities Type: SMB Activities: deeptech biotech Technologies: Synthetic Biology | 1 | 71 |
 | Nagi Bioscience in vivo testing at the in vitro scale At Nagi Bioscience, we develop cutting-edge biological testing solutions enabling scientists to generate the insights they need to fuel life-changing discoveries in a faster, more efficient, and ethical way. Our pioneering Organism-on-Chip platform, SydLabTM One, seamlessly integrates into existing lab environments, enabling scientists to enhance efficiency, accuracy, and reproducibility like never before. By combining this innovative technology with our team’s expertise, we deliver customer-focused solutions that empower scientists to advance research and drive scientific thinking forward. #inwormwetrust Microfluidic technology, Drug Screening, Pre-clinical studies, Lab Automation Technology, Safety and Efficacy, Toxicology, AI, C. … 184 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 3 | 42 |
 | Kyowa Kirin, Inc.- U.S. Kyowa Kirin North America is a specialty pharmaceutical company dedicated to making a profound impact on patient lives. Kyowa Kirin is a global specialty pharmaceutical company that applies state-of-the-art biotechnologies to discover and deliver novel medicines. We work on some of the hardest to treat diseases where need is high, and potential for life-changing impact is possible. The North America organization includes offices in Princeton, NJ; Toronto, Canada and a research facility in La Jolla, CA. Together, we work as a collaborative team to understand clinical needs and advance innovations that have a profound impact on patient lives. Our growth … 59 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 3 | 732 |
 | Alvotech Better Access. Better Lives. Our mission is to improve patient lives and the sustainability of the global healthcare ecosystem by broadening the availability and accessibility of biosimilars. Biopharmaceuticals, Research and Development, Biosimilars, Biotechnology, Pharmaceutical, Biogenerics, Health, Cell Line Development, Business Development, and Regulatory 232 similar entities Type: Startup Activities: biotech deeptech healthtech Technologies: Synthetic Biology | 0 | 895 |
 | Phacilitate Through conferences, community and market insights, we create partnerships that help advance the next pillar of medicine Phacilitate creates an environment where promising innovation can turn into the products that are changing the future of medicine. Recognised as the market leader in providing the life science sector with strategic insight, inspiration and unparalleled business networking, Phacilitate enables professionals to stay abreast of the issues driving life science innovation. #advancedtherapies #biotech #celltherapy #genetherapy Clinical Development, Cell Therapy, Gene Therapy, Oncology, Cancer, Precision Medicine, Biotech, Advanced Therapy, Biotechnology, and Life Sciences 196 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 21 | 17 |
 | Microtech S.R.L. The logical choice. The microtech was born in 1964 from an idea of the Gaetano Papagno founder. It is based in Naples and specializes in the promotion, sale and distribution of consumer products, reagents and equipment for molecular, mobile, genetic and biochemical biology in all laboratories of the scientific research centers, universities, C.N.R., industries, hospitals and private individuals. The seriousness, commitment and scrupulousness are the principles that distinguish it, which are recognized by both customers and suppliers. For over 40 years our goal has been to create, in central southern Italy, a quality organization that contributes, with its products and … 73 similar entities Type: SMB Activities: deeptech biotech Technologies: Synthetic Biology | 2 | 30 |
 | The Science Advisory Board The source of discovery and development in the life sciences. The Science Advisory Board is a global community of scientists and medical professionals from around the world. Manufacturers of laboratory instruments and consumables, pharmaceutical and medical device companies, financial institutions and government agencies rely on the perspectives of our members when making important decisions. life science, molecular biology, cell biology, molecular diagnostics, drug discovery, bioprocessing, clinical chemistry, microbiology, proteomics, genomics, gene therapy, immunology, medicinal chemistry, stem cell biology, pathology, and analytical chemistry 70 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 26 | 11 |
 | Kernal Biologics KernalBio creates mRNA therapies that instruct specific cells on how to make their own medicine Kernal creates mRNA therapies to cure severe diseases including cancer. Our mRNA therapies instruct specific cells on how to make their own drugs. With roots at MIT, Harvard and Big Pharma, our team previously built a successful Biotech company and has deep expertise in mRNA space. synthetic biology, RNA design, immunotherapy, covid-19, cancer, and mRNA therapy 108 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 10 | 15 |
 | Basecamp Research Beyond Known Biology: The world's largest foundational biodiversity database for training AI Basecamp Research is an AI company dedicated to solving the most pressing challenges in the life sciences by exploring beyond known biology. The company discovers and designs proteins with artificial intelligence trained on its proprietary knowledge graph of nature, the largest and most diverse of its kind, to design biological solutions for pharma, food and industrial applications. Understanding the full genetic, evolutionary, and environmental context of each protein allows Basecamp Research to design tailored proteins for specific applications without the need for expensive and time-consuming directed evolution campaigns. … 73 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology SaaS A.I. | 16 | 47 |
 | PartitionBio Ltd Exploiting a proprietary tech platform to develop biomolecular tools for therapeutic & synthetic biology applications PartitionBio Exploiting a novel proprietary technology platform to develop biomolecular tools for the use in therapeutic and synthetic biology applications. contact@partitionbio.co.uk 328 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 0 | 13 |
 | Isomorphic Labs We are reimagining the entire drug discovery process from first principles with an AI-first approach. Isomorphic Labs is a new Alphabet company and commercial venture which aims to reimagine the entire drug discovery process from first principles with an AI-first approach, and, ultimately, to model and understand some of the fundamental mechanisms of life. Using computational advances, we’re working at the cutting edge in the new era of ‘digital biology’. By significantly increasing the pace of scientific research and efficacy of new medicines, we will be at the forefront of breakthroughs that will benefit millions of people. 77 similar entities Type: Startup Activities: deeptech biotech Technologies: A.I. | 2 | 202 |
 | Recursion Decoding Biology to Radically Improve Lives We are a clinical-stage TechBio company decoding biology by integrating technological innovations across biology, chemistry, automation, data science and engineering to industrialize drug discovery. We are leveraging new technology to create virtuous cycles of learning around datasets to build the next-generation biopharmaceutical company. It’s complex biology, decoded. While we are united in a common mission, Decoding Biology to Radically Improve Lives, our greatest strength lies in our differences: expertise, gender, race, disciplines, experience, and perspectives. Deliberately building and cultivating this culture is critical to achieving our audacious goals. We are proudly headquartered in Salt … 67 similar entities Type: Startup Activities: biotech deeptech Technologies: A.I. A.I. - Machine Learning Synthetic Biology | 26 | 942 |
 | Elixirgen Scientific Transform how you model human biology. Elixirgen Scientific is a global leader in regenerative medicine and biotechnology, headquartered in the Science + Technology Park at the Johns Hopkins Medical Campus in Baltimore, MD. Our mission is to advance science and medicine with fast, functional, and scalable induced pluripotent stem cell (iPSC) differentiation products and services. Our state-of-the-art, transcription-factor-based technology allows you to overcome the high cost and inefficiencies associated with lengthy cell differentiation periods. We empower research institutions, pharmaceutical organizations, and biomedical enterprises worldwide, even those with no previous iPSC experience, by increasing access to relevant cells for modeling human … 75 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 1 | 17 |
 | DIANA Biotechnologies DIANA Biotechnologies: Diversified Biotech We are leading Czech biotechnology company with a great innovative potential. We focus on the development of products based on our cutting edge research in the fields of molecular diagnostics and drug discovery. We have global ambitions and since our foundation in 2018 we already have achieved some of our goals. During COVID-19 pandemics, we were able to quickly develop one of the most innovative COVID-19 tests worldwide and we helped to increase the testing capacity of the whole country. As a result, we became the biggest Czech manufacturer of RT-PCR tests. Besides RT-PCR, we continue … 59 similar entities Type: Startup Activities: biotech deeptech manufacturing Technologies: Synthetic Biology | 3 | 59 |
 |  PlateletBio Allogeneic Cell Therapy Platform that Leverages Natural Platelet Biology PlateletBio is an allogeneic cell therapy company focused on platelet biology. We are pioneers, discovering a new category in therapeutics. Our approach is one-of-a-kind, recreating nature’s legendary delivery cell. In doing so, we’re developing a cell therapy empowered to tackle previously unmet medical challenges. biotechnology, platelets, and drug discovery 124 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 6 | 4 |
 | Fraunhofer Institute for Interfacial Engineering and Biotechnology We combine biology and engineering The Fraunhofer Institute for Interfacial Engineering and Biotechnology IGB develops and optimizes processes, technologies, and products for health, sustainable chemistry and the environment. In doing so, we rely on the unique combination of expertise in biology and the engineering sciences in order to contribute to human welfare, a sustainable economy, and an intact environment with the systems approach of bioeconomy as well as bioinspired, biointegrated and biointelligent solutions. Working closely with partners from universities and industry, the IGB covers the entire innovation chain from fundamental research to industrial implementation. We provide our customers with research … 60 similar entities Type: SMB Activities: deeptech biotech Technologies: New Materials Synthetic Biology | 13 | 218 |
 | BIOTECanada Solving for today. Building for tomorrow. BIOTECanada is the national industry association voice. With over 230 member companies, the Association’s membership is representative of the broader Canadian biotech ecosystem which is national in scope and comprised of pre-commercial biotech companies, global pharma and biotech companies, investors, incubator and accelerator organizations, and academia. In the context of global population growth and corresponding climate change, food sustainability, and human health needs, the biotechnology industry plays a vital role in developing solutions to help address the resulting human health and environmental challenges. 78 similar entities Type: SMB Activities: deeptech biotech Technologies: Decarbonization | 26 | 25 |
 | Life Sciences BC “Inspiring Minds Advancing Science” Life Sciences BC is a not-for-profit, non-government, industry association that supports and represents the life sciences community of British Columbia through leadership, facilitation of investment and partnering, advocacy, and promotion of our world-class science and industry. Biopharmaceuticals, Medical Devices, Medical Technologies, and Digital Health Care 321 similar entities Type: SMB Activities: healthtech biotech deeptech Technologies: Synthetic Biology | 34 | 29 |
 | Biocentis We are a biotechnology company developing ground-breaking solutions to control the world’s most dangerous insect species Biocentis is an Imperial College London spin-out on a mission to develop eco-friendly genetic solutions to effectively and safely control the dangerous insect species that spread disease to humans, reduce biodiversity, or threaten food security. We leverage CRISPR to develop self-limiting gene drive technologies that are biological, environmentally friendly, and can be tailored to obtain levels of control that are suitable for a broad range of applications. Building on a unique proprietary technological platform, invented by our founders at Imperial College London and applicable … 19 similar entities Type: Startup Activities: deeptech Technologies: Decarbonization | 2 | 19 |
 | Chromodynamics Taking the guesswork out of drug development At Chromodynamics, we are on a mission to deliver instruments that eliminate guesswork from drug development and prescription. Our unique technology allows for an enormous improvement in speed, efficacy, and cost with which exciting new treatments like immunotherapy are developed. We have been recognised as one of the most promising startups in the Eindhoven Brainport region and are expanding our team to ramp up our product development. Imaging systems, Multispectral imaging, Real-time analysis, Chemical imaging, Spectroscopy, Scientific instruments, Contract research, and Data analysis 250 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 0 | 7 |
 | Cradle Design better proteins. We believe Cells can theoretically produce almost anything, from fabrics to food, fuel and medicines. Designing cell-factories is hard, but our tools and machine-learning models can make it easier. Our mission is to ultimately help replace traditional farms and factories for a more sustainable world. Jobs: https://jobs.cradle.bio protein design, machine learning, protein activity, protein stability, protein secretability, protein , protein structure, metabolic engineering, protein engineering, and protein solubility 79 similar entities Type: Startup Activities: biotech Technologies: Synthetic Biology | 4 | 75 |
 | Ferment We incubate, fund, and launch new companies that use programmed biology to shape the human future. Ferment is a venture studio building new companies that rapidly translate biology into products that solve targeted problems across industrial and consumer markets including food & nutrition, industrials & waste, materials, consumer health and more. synbio, synthetic biology, biotech, programmed biology, venture studio, company creation studio, incubator, venture capital, biotechnology, industrial biotechnology, and consumer biotechnology 122 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 1 | 8 |
 | Dompé We Embrace the Challenge in Science Dompé farmaceutici is an international biopharmaceutical company involved in all activities of the pharmaceutical value chain, from research to development, production and marketing. As a long-established family company, we blend the stability that comes from our 130-year heritage with the agility and dynamism of a start-up. We can turn transformative breakthroughs into treatments because we have the right qualities and capabilities to deliver new drugs. Our 160,000 square meter R&D and production site in L’Aquila, Italy, is the heart of Dompé. Here, we conduct vital research, and produce and distribute our primary care and … 84 similar entities Type: SMB Activities: biotech deeptech manufacturing Technologies: Synthetic Biology | 26 | 1,007 |
 | Revance Revance is a biotechnology company setting the new standard in healthcare with innovative aesthetic and therapeutic offerings that elevate patient and physician experiences. Botulinum Toxin, biotechnology, biotech, healthcare, pharmaceuticals, science, research, financial services, and fintech 354 similar entities Type: SMB Activities: biotech deeptech healthtech Technologies: Synthetic Biology | 4 | 602 |